000 01200 a2200349 4500
005 20250517174835.0
264 0 _c20190702
008 201907s 0 0 eng d
022 _a1535-4970
024 7 _a10.1164/rccm.201709-1831LE
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLipson, David A
245 0 0 _aReply to Suissa and Ariel: The FULFIL Trial.
_h[electronic resource]
260 _bAmerican journal of respiratory and critical care medicine
_c02 2018
300 _a542-543 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
650 0 4 _aPulmonary Disease, Chronic Obstructive
700 1 _aBarnacle, Helen
700 1 _aBirk, Ruby
700 1 _aBrealey, Noushin
700 1 _aLocantore, Nicholas
700 1 _aLomas, David A
700 1 _aLudwig-Sengpiel, Andrea
700 1 _aMohindra, Rajat
700 1 _aTabberer, Maggie
700 1 _aZhu, Chang-Qing
700 1 _aPascoe, Steven J
773 0 _tAmerican journal of respiratory and critical care medicine
_gvol. 197
_gno. 4
_gp. 542-543
856 4 0 _uhttps://doi.org/10.1164/rccm.201709-1831LE
_zAvailable from publisher's website
999 _c27604176
_d27604176